Johnson & Johnson, Merck, Bristol-Myers Squibb, and dozens of major and mid-size pharmaceutical companies have established significant New Jersey operations, creating the densest pharmaceutical trademark filing concentration outside of Massachusetts’s Cambridge biotech cluster. New Jersey’s financial services community in Jersey City, which has grown substantially as a New York City financial satellite, its logistics and distribution industry serving the port of Newark; and a consumer goods, food, and retail sector serving the dense New York metro area population all create trademark protection needs across a wide range of commercial categories.

New Jersey’s Division of Revenue and Enterprise Services handles state trademark registration matters. For New Jersey’s pharmaceutical companies competing in national and international drug markets, for Jersey City financial services firms serving national institutional clients, and for New Jersey consumer brands distributed through the New York metro retail ecosystem, federal USPTO registration is the commercially relevant filing. USTML provides trademark registration, renewal, and monitoring for New Jersey businesses with the specific understanding of the pharmaceutical, financial services, and consumer brand trademark challenges that characterize New Jersey’s commercially dense and nationally integrated market.